The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization

The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization

BackgroundTransarterial chemoembolization(TACE) is the suggested treatment for hepatocellular carcinoma (HCC) not amenable to curative treatments. We investigated the role of sarcopenia on overall survival in HCC patients receiving TACE and proposed a new prognostic scoring system incorporating sarc...

Full description

Bibliographic Details
Main Authors: Tzu-Ping Chien, Song-Fong Huang, Wen-Hui Chan, Kuang-Tse Pan, Ming-Chin Yu, Wei-Chen Lee, Hsin-I Tsai, Po-Ting Lin, Hsing-Yu Chen, Jui-Hsuan Chen, Chao-Wei Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
sarcopenia
transarterial chemoembolization (TACE)
survival (MeSH)
biochemical factors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1005571/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1005571/full

Similar Items